Cargando…
Downregulation of TRPC4 and TRPC5 Inhibits Smooth Muscle Cell Proliferation without Affecting Endothelial Cell Proliferation
AIMS: The main treatment for coronary heart disease is percutaneous coronary intervention (PCI), and drug-eluting stents are designed to inhibit vascular smooth muscle cell (VSMCs) proliferation and migration causing restenosis by releasing pharmacological agents into the vessel wall. Once drug-elut...
Autores principales: | Zeng, Wenjun, Ji, Yinan, Zhang, Haiping, Chen, Liusheng, Du, Li, Guo, Ruiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643255/ https://www.ncbi.nlm.nih.gov/pubmed/34899056 http://dx.doi.org/10.1155/2021/2949986 |
Ejemplares similares
-
Homer binds to Orai1 and TRPC channels in the neointima and regulates vascular smooth muscle cell migration and proliferation
por: Jia, Shuping, et al.
Publicado: (2017) -
The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing
por: Sexton, Jane E., et al.
Publicado: (2016) -
TRPC1/TRPC3 channels mediate lysophosphatidylcholine-induced apoptosis in cultured human coronary artery smooth muscles cells
por: Wang, Yuan, et al.
Publicado: (2016) -
TRPC6 and TRPC4 Heteromultimerization Mediates Store Depletion-Activated NCX1 Reversal in Proliferative Vascular Smooth Muscle Cells
por: Zhang, Bin, et al.
Publicado: (2018) -
TRPC3 Regulates the Proliferation and Apoptosis Resistance of Triple Negative Breast Cancer Cells through the TRPC3/RASA4/MAPK Pathway
por: Wang, Yan, et al.
Publicado: (2019)